NEWS – Next PrimeVigilance Learning Pharmacovigilance Webinar

 

In this new webinar, our expert speakers Dr. Marcela Fialova and Dr. Jana Hyankova will give their insight into Covid-19’s impact on the EU and the UK pharmacovigilance processes, highlighting the challenges that the Pharmaceutical Industry has had to face and how they adapted.

Choose between one of 2 sessions available for this webinar:

• Session 1: 4 May, 10am EST / 3pm GMT / 4pm CET
• Session 2: 4 May, 2pm EST / 7pm GMT / 8pm CET

Key learnings include:

• Impacts of the COVID-19 pandemic for global pharma companies
• Updates of EU PV legislation with respect to COVID-19
  • COVID-19 terms to MedDRA
    • Pharmacovigilance activities with respect to COVID-19 vaccines
      • RMP, Periodic Safety Report, Signal Management, etc.

At the end of the webinar, you will have the opportunity to ask our experts any questions you may have.

About our expert speakers:

Marcela Fialova, MD – PrimeVigilance, Senior Director, EU QPPV, UK QPPV

Marcela is a pharmacovigilance professional with more than 20 years of experience in the pharmaceutical business. She has spent the majority of this time in pharmacovigilance, as well as quality assurance, auditing, and regulatory affairs. She has broad experience in many pharmacovigilance areas (e.g., risk management, PV systems, medical writing) and currently acts as EU/UK QPPV for several clients.
Click here for more details. 

Jana Hyankova, MD – PrimeVigilance, Director, EU QPPV, UK QPPV

Jana is an expert in pharmacovigilance with more than 15 years of working experience from several global pharma companies. She joined PrimeVigilance in 2014 and she currently holds the position of PV Director. She serves as EU QPPV for several clients and conducts PV audits as requested by clients.
Click here for more details. 

If you have any questions  about our webinar please feel free to contact us